Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

v3.20.2
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
CASH FLOWS FROM OPERATING ACTIVITIES    
Net income (loss) $ (1,363,964) $ 254,851
Reconciling items:    
Depreciation 184,391 163,004
Amortization 180,394 166,040
Amortization of non-recoupable ticketing contract advances 38,833 54,120
Deferred income tax benefit (22,615) (1,008)
Amortization of debt issuance costs and discounts 24,201 16,300
Non-cash compensation expense 106,965 36,924
Unrealized changes in fair value of contingent consideration (25,745) 7,372
Equity in losses of nonconsolidated affiliates, net of distributions 8,266 6,526
Provision for uncollectible accounts receivable 48,413 14,413
Other, net (15,160) (9,177)
Changes in operating assets and liabilities, net of effects of acquisitions and dispositions:    
Decrease (increase) in accounts receivable 406,202 (392,065)
Decrease (increase) in prepaid expenses and other assets 1,793 (257,268)
Increase (decrease) in accounts payable, accrued expenses and other liabilities (1,213,409) 135,672
Increase (decrease) in deferred revenue 684,532 (162,782)
Net cash provided by (used in) operating activities (956,903) 32,922
CASH FLOWS FROM INVESTING ACTIVITIES    
Advances of notes receivable (12,232) (24,110)
Collections of notes receivable 13,838 10,142
Investments made in nonconsolidated affiliates (9,728) (34,742)
Purchases of property, plant and equipment (187,036) (225,822)
Cash paid for acquisitions, net of cash acquired (37,283) (108,075)
Purchases of intangible assets (3,903) (22,953)
Other, net 11,812 2,203
Net cash used in investing activities (224,532) (403,357)
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from long-term debt, net of debt issuance costs 1,608,462 604
Payments on long-term debt (24,202) (30,491)
Contributions from noncontrolling interests 2,568 13,124
Distributions to noncontrolling interests (31,473) (73,182)
Purchases and sales of noncontrolling interests, net (106,971) (29,005)
Proceeds from exercise of stock options 18,092 13,240
Taxes paid for net share settlement of equity awards (42,818) (10,578)
Payments of Merger Related Costs, Financing Activities (62,035) (23,322)
Other, net 13 0
Net cash provided by (used in) financing activities 1,361,636 (139,610)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (20,952) (59,364)
Net increase (decrease) in cash, cash equivalents, and restricted cash 159,249 (569,409)
Cash, cash equivalents, and restricted cash at beginning of period 2,474,242 2,378,203
Cash, cash equivalents, and restricted cash at end of period $ 2,633,491 $ 1,808,794